Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-30

Clinical Trial Update: Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Erectile Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the effectiveness and safety of adipose-derived regenerative cells for erectile dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adipose-derived Regenerative Cells (Adipose-derived Regenerative Cells)

Snippet

Sponsor: Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | Conditions: Erectile Dysfunction, Impotence, Vasculogenic | Phase 1, Phase 2 | Status: COMPLETED